Collaboration in action: McLaren Racing and Sanofi M&S Teams working together at our M&S site in Frankfurt, Germany to drive performance excellence and innovation in biopharma.

Collaboration in action: McLaren Racing and Sanofi M&S Teams working together at our M&S site in Frankfurt, Germany to drive performance excellence and innovation in biopharma.

Driving Excellence in Biopharma

Our Formula for Success with McLaren Racing


Our Latest Stories

Our Science

June 10, 2025

Advancing Patient- and Provider-Centric Care in Multiple Myeloma

Our Science

June 6, 2025

Tackling Atopic Dermatitis From Multiple Angles

A scientist examines a petri dish under bright light in a lab. Digital data streams flow from the dish to a computer screen.

Our Science

May 28, 2025

A New Era of Biopharma Production with AI

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Science

We turn the impossible into possible.

Your Health

We chase the miracles of science to improve people’s lives. 

Our Commitment

We have reimagined a bold sustainable approach.

Our Pipeline

5

Therapeutic areas

86

Compounds in clinical development

24

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


June 9, 2025
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

June 7, 2025
Media Update: RAD: Dupixent data reinforce use in atopic dermatitis patients with skin of color

June 6, 2025
Media Update: ISTH: new data highlight innovation from Sanofi’s pipeline in rare diseases

June 5, 2025
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan